AstraZeneca

We're proud to be recognised among the top 3 in the 2026 Access to Medicine Index. By 2030, we aim to reach 400 million people from underserved communities with our medicines and Health Equity programmes.

Read more about our results: learn.az/6018By8VU4

@AtMIndex

#HealthEquity #ATMIndex10 #AccessToMedicine

For #Investors and #Media only.

Our 9M and Q3 2026 results are now available, highlighting continued strong commercial performance, with Total Revenue up 7%.

Learn more: learn.az/6015BHokeN

#AZN #FinancialResults $AZN

For #Investors:

We’ll be sharing our 9M and Q3 2026 performance update at 07:00 GMT on 30 October 2026.

An accompanying webcast for investors and analysts will take place at 14:30 GMT. Register to attend virtually here: learn.az/6016BHkNas

$AZN

🧬Today marks the opening of our new global R&D centre in Cambridge, Massachusetts, US.

Bringing together exceptional talent and cutting-edge technologies to help accelerate scientific discovery and advance the next generation of medicines. Learn more: learn.az/6016BGLoRQ

$AZN #WhatScienceCanDo

At #ClimateWeekNYC, we shared how partnership is critical for healthier people, health systems and the planet.

Highlights included: our $100m Young Health Programme commitment, a new tool that models the environmental impact of care pathways and the European Network on Climate and Health Education reaching 6,000 medical students.

Thanks to colleagues, partners and young leaders who made this progress possible.